U.S. FDA Panel Narrowly Backs Merck’s at-Home COVID-19 Pill

A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co’s antiviral pill to treat COVID-19. Read More